Home
Inbox
Search
Speaker
Alejhandra Lei
MD
AstraZeneca
Bookmark
Session(s)
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Trial of AZD8871, a Novel Dual-Act...
Monday, May 21
9:15 AM - 9:30 AM
All-Cause Mortality in COPD Patients Treated with Aclidinium and Other Inhaled Bronchodila...
Monday, May 21
2:15 PM - 4:15 PM
An Ascending, Repeat-Dose Safety and Tolerability Study of AZD8871 a Novel, Dual-Acting Br...
Tuesday, May 22
11:15 AM - 1:00 PM
Home
Inbox
Search